Ibires I Nexpule Benefits & Uses

Ibires I Nexpule is used to treat the following -

Other Benefits

COPD

Ibires I Nexpule Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: COPD (Chronic Obstructive Pulmonary Disease) Before or After Meal: As advised by a physician Single Maximum Dose: 3 ml Dosage Route: Inhalational Frequency: 4 daily Course Duration: As directed by the doctor Special Instructions: strength 2.5 mg Salbutamol and 0.5 mg of ipratropium in 3 ml
Geriatric	Disease: COPD (Chronic Obstructive Pulmonary Disease) Before or After Meal: As advised by a physician Single Maximum Dose: 3 ml Dosage Route: Inhalational Frequency: 4 daily Course Duration: As directed by the doctor Special Instructions: strength 2.5 mg Salbutamol and 0.5 mg of ipratropium in 3 ml

Ibires I Nexpule Related Warnings

Is the use of Ibires I Nexpule safe for pregnant women?

Ibires I shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Ibires I Nexpule safe during breastfeeding?

Women who are breastfeeding may experience severe harmful effects after taking Ibires I. It should only be taken after medical advice.
What is the effect of Ibires I Nexpule on the Kidneys?

Very few cases of side effects of Ibires I on kidney have been reported.
What is the effect of Ibires I Nexpule on the Liver?

Ibires I can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ibires I Nexpule on the Heart?

You may experience side effects on your heart after taking Ibires I. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.

Severe Interaction of Ibires I Nexpule with Other Drugs

Ibires I Nexpule should not be taken with following medicines due to severe side effects it may cause to patients -

Moderate

Aspirin

Fluticasone

Atropine

Aripiprazole

Scopolamine

Scopolamine Tablet

Glycopyrrolate

Dicyclomine

Benztropine

Benztropine Tablet

Tiotropium

Atenolol

Propranolol

Furosemide

Aspirin

Cyanocobalamin

Aspirin(ASA)

Mild

Ibires I Nexpule Contraindications

If you are suffering from any of the following diseases, you should not take Ibires I Nexpule unless your doctor advises you to do so -

Glaucoma
Gastritis
Drug Allergy
Liver Disease
Tachycardia
Urinary Retention
Diabetes
Potassium Deficiency
Kidney Disease
Heart Disease
Asthma

Frequently asked Questions about Ibires I Nexpule

Is this Ibires I Nexpule habit forming or addictive?

Ibires I Nexpule is not addictive in nature.

Ibires I Nexpule Interactions with Food and Alcohol

Interaction between Food and Ibires I Nexpule

Information is not available on the interaction of any foods with Ibires I Nexpule, due to a lack of research on this.
Interaction between Alcohol and Ibires I Nexpule

It is difficult to say anything about the effect of Ibires I Nexpule and alcohol. No research has been done on this yet.

See all substitutes for Ibires I

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 705

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 116

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atrovent® HFA (ipratropium bromide HFA)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ipravent® (ipratropium bromide)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120

Ibires I Nexpule